This trial is designed to see if using a PET scan and a perfusion scan before and during radiation therapy for lung cancer helps to predict how well the treatment works and how well the lung functions during treatment.
4 Primary · 2 Secondary · Reporting Duration: Up to 60 months
1 Treatment Group
Response-driven Adaptive RT
1 of 1
49 Total Participants · 1 Treatment Group
Primary Treatment: V/Q SPECT · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What prior experimentation has been conducted with V/Q SPECT?
"Currently, there exist 1435 studies exploring the efficacy of V/Q SPECT. Of these trials, 365 are in Phase 3 development and 74833 sites across Shanghai are hosting them." - Anonymous Online Contributor
How many participants are currently being accepted for this research trial?
"Unfortunately, this research project has closed its doors to new participants. The trial was first uploaded on January 14th 2016 and the latest update happened on December 17th 2021. If you are seeking other trials, there are 1365 studies for carcinoma non-small cell lung cancer patients actively recruiting and 1435 V/Q SPECT clinical trials searching for volunteers." - Anonymous Online Contributor
How is V/Q SPECT customarily deployed in clinical practice?
"V/Q SPECT has traditionally been used for palliative care, but it can also be employed to treat a range of medical conditions such as malignant peritoneal neoplasm in newly diagnosed patients." - Anonymous Online Contributor
Are there available slots for participants in this clinical trial?
"This clinical trial, initially posted on January 14th 2016 and last updated December 17th 2021 is no longer recruiting according to the data hosted by clinicaltrials.gov. Nonetheless, there are presently 2,800 other medical studies actively seeking out participants." - Anonymous Online Contributor